No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
280 |
4. Check minimum number of eventsNone |
280 |
5. Include endpointsNone |
280 |
6. Filter based on genotype QC (FinnGen only) |
253 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H05
- Name in latin
- Inflammatio orbitae acuta
Similar endpoints
↥List of similar endpoints to
Acute inflammation of orbit
based on the number of shared cases.
Similar with more cases:
- Disorders of orbit
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2945 | 1284 | 1650 |
| Only index persons | 2527 | 1123 | 1404 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.05 |
| Only index persons | 0.05 | 0.04 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 24.56 | 30.24 | 19.99 |
| Only index persons | 23.68 | 29.27 | 19.21 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 253 | 138 | 115 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 46.72 | 46.26 | 47.27 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 258
- Matched controls
- 2580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
264.2
206
*
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
135.6
43.3
45
*
3760A
ICD-9 Finland
Disorders of the orbit, Acute inflammation of orbit
+∞
33.0
31
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.4
24.9
29
31
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
7.7
24.5
37
55
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
84.0
21.0
23
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.5
19.9
27
35
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
19.4
78
268
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.4
16.9
36
75
CAA00
NOMESCO Finland
Puncture of orbital abscess
+∞
15.8
15
*
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
4.9
15.0
36
83
H01.0
ICD-10 Finland
Blepharitis
5.5
14.7
30
60
H57.1
ICD-10 Finland
Ocular pain
5.9
13.8
26
48
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
+∞
13.7
13
*
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
13.7
13
*
H04.10
ICD-10 Finland
Dry eye syndrome
4.8
13.6
33
77
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
10.5
13.1
25
26
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
+∞
12.6
12
*
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
+∞
12.6
12
*
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
12.5
32
78
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
12.4
114
603
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.7
12.2
92
441
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
11.9
83
382
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
11.5
11
*
36900
ICD-8 Finland
Other inflammatory diseases of eye, Abscessus orbitae
+∞
11.5
11
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.6
11.3
90
441
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
29.5
10.8
14
5
H02AB06
ATC
prednisolone; systemic
2.4
10.7
134
803
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
10.5
10
*
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
+∞
10.5
10
*
CA1AD
NOMESCO Finland
Orbita CT
+∞
10.5
10
*
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
34.1
10.4
13
*
UDM02
NOMESCO Finland
Sinoscopy
9.7
9.7
19
21
XCK10
NOMESCO Finland
Photography of fundus of eye
3.6
9.7
34
104
WX002
NOMESCO Finland
Sedation and analgesia
2.8
9.7
55
225
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.8
9.5
31
90
CA1BD
NOMESCO Finland
Extensive orbita CT
+∞
9.4
9
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.3
8.7
35
117
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.5
8.7
32
101
J31.0
ICD-10 Finland
Chronic rhinitis
3.3
8.6
34
112
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.4
8.5
33
108
H02AB07
ATC
prednisone; oral
3.0
8.5
42
159
36902
ICD-8 Finland
Other inflammatory diseases of eye, Tenonitis
+∞
8.4
8
*
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
8.4
8
*
Z97.0
ICD-10 Finland
Presence of artificial eye
+∞
8.4
8
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.7
8.0
19
43
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
7.9
119
743
XCK00
NOMESCO Finland
Perimetry
4.4
7.9
20
48
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
25.9
7.6
10
*
F29
ICPC
Eye symptom/complaint other
2.9
7.5
39
151
R01AD09
ATC
mometasone; nasal
2.1
7.4
127
826
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
+∞
7.3
7
*
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
7.3
7
*
H05.8
ICD-10 Finland
Other disorders of orbit
+∞
7.3
7
*
ZXA00
NOMESCO Finland
Right side
2.3
7.3
68
349
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
7.3
35
130
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
31.0
7.2
9
*
J01.4
ICD-10 Finland
Acute pansinusitis
20.7
7.2
10
5
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.9
7.1
35
132
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
7.1
36
138
J01MA14
ATC
moxifloxacin; systemic
3.2
7.1
29
98
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
7.0
6.9
16
24
S01AD03
ATC
aciclovir; ophthalmic
6.4
6.9
17
28
Z3231
NOMESCO Finland
Registered nurse
2.2
6.9
77
425
N02AX02
ATC
tramadol; systemic, rectal
2.0
6.9
112
711
J01FF01
ATC
clindamycin; systemic
2.1
6.9
79
441
ZXE00
NOMESCO Finland
One hour or less
2.0
6.8
102
628
H02.4
ICD-10 Finland
Ptosis of eyelid
41.2
6.8
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.2
6.7
71
383
H16.9
ICD-10 Finland
Keratitis, unspecified
9.1
6.6
13
15
J01DB01
ATC
cefalexin; oral
2.5
6.6
221
1812
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
6.5
96
586
WX720
NOMESCO Finland
Own respiration
3.9
6.5
19
51
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
11.4
6.4
11
10
CAE10
NOMESCO Finland
Revision and secondary implant in orbit
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.2
57
289
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
6.2
119
793
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
6.1
46
215
ZXA05
NOMESCO Finland
Left side
2.2
6.0
61
322
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
22
54
4.36
8.44
1.9
1.8
1.36
4.57
iu/l
1.35
12
20
169
1215
2.13
7.61
15.8
10.2
4.28
3.97
e9/l
0.78
155
1071
61
308
2.28
6.78
2.5
1.8
—
—
—
0
0
20
56
3.79
6.45
1.3
1.2
—
—
—
0
0
127
857
1.95
6.43
7.6
4.9
35.26
36.39
g/l
1.46
121
824
41
185
2.45
5.83
5.7
4.8
1.14
1.80
mmol/l
0.61
35
156
101
652
1.90
5.67
2.6
2.4
69.19
62.26
u/l
0.16
94
609
161
1213
1.87
5.48
8.0
4.6
6.75
6.52
mmol/l
0.65
148
1126
18
53
3.58
5.41
2.0
1.7
—
—
—
0
0
92
584
1.89
5.39
3.3
2.1
182.55
198.41
u/l
0.10
84
556
34
148
2.49
5.21
1.9
1.2
236.97
357.91
u/ml
0.39
34
139
133
956
1.81
5.16
14.8
7.2
1.20
1.21
mmol/l
0.81
122
837
122
858
1.80
5.07
13.0
6.5
1.21
1.21
mmol/l
0.21
117
801
11
16
7.13
5.00
1.5
1.5
3.11
3.74
u/ml
—
11
10
25
96
2.78
4.89
2.1
1.7
—
—
—
0
0
82
519
1.85
4.75
2.9
2.2
2.86
2.89
mg/l
0.04
76
456
17
53
3.36
4.70
1.6
1.7
—
—
—
0
0
15
43
3.64
4.69
1.5
1.5
—
—
—
0
0
24
93
2.74
4.62
1.3
2.6
5.40
6.36
iu/ml
—
5
23
19
65
3.08
4.55
1.6
1.7
—
—
—
0
0
193
1586
1.86
4.49
12.4
7.9
82.72
79.33
u/l
0.38
184
1501
10
16
6.45
4.33
2.5
4.3
2909.90
853.06
u/ml
—
10
16
53
299
1.97
4.31
4.0
2.5
2.36
2.41
g/l
0.25
48
275
18
62
3.05
4.26
1.8
1.5
—
—
—
0
0
65
395
1.86
4.23
1.4
1.3
43.47
29.03
iu/ml
0.43
14
124
145
1110
1.70
4.19
8.6
6.6
10.15
11.38
umol/l
1.39
138
1060
14
35
4.17
4.17
1.5
1.5
—
—
—
0
0
14
35
4.17
4.17
1.5
1.4
—
—
—
0
0
15
47
3.33
4.12
1.3
1.0
—
—
—
0
0
15
47
3.33
4.12
1.1
2.1
—
—
—
0
0
55
322
1.90
4.00
3.9
2.5
13.48
13.23
umol/l
0.08
49
298
17
60
2.96
3.87
1.4
1.2
—
—
—
0
0
96
671
1.69
3.82
3.5
3.3
2.34
2.35
mmol/l
0.29
88
625
28
129
2.31
3.80
1.7
1.6
—
—
—
0
0
40
215
2.02
3.71
1.9
1.6
—
—
—
0
0
115
849
1.64
3.67
2.2
1.9
94.03
98.43
pmol/l
0.46
64
447
14
46
3.16
3.58
11.1
2.0
1.57
1.39
ratio
—
9
22
41
226
1.97
3.55
2.0
1.5
—
—
—
0
0
121
912
1.62
3.51
2.6
2.6
72.66
75.34
nmol/l
0.43
115
831
16
58
2.87
3.49
1.3
1.2
—
1.07
—
0
6
17
65
2.73
3.37
3.5
2.8
—
—
—
0
0
186
1566
1.67
3.37
6.8
4.0
13.82
10.39
mm/h
2.04
175
1474
12
33
3.76
3.34
1.3
1.1
—
—
—
0
0
30
154
2.07
3.15
1.1
1.2
28.34
131.41
u/ml
—
8
61
105
781
1.58
3.13
4.3
3.2
40.80
31.11
u/l
0.76
96
743
31
162
2.04
3.11
12.7
8.0
9.24
8.06
mmol/l
0.49
31
153
25
120
2.20
3.10
2.2
4.0
4.61
4.68
pmol/l
0.15
25
108
40
229
1.88
3.10
7.4
4.5
233.85
234.34
u/l
0.01
40
221
235
2138
2.11
3.03
26.3
13.3
23.99
23.30
mg/l
0.12
205
1716
56
358
1.72
3.02
4.4
3.4
415.45
236.53
ng/l
0.29
38
252
15
57
2.73
3.02
2.0
1.5
132.60
125.46
au/ml
—
5
21
73
501
1.64
3.02
3.4
2.4
—
—
—
0
0
34
187
1.94
2.96
2.6
2.6
0.19
0.22
g/l
1.56
34
176
18
76
2.47
2.96
3.2
2.2
—
—
—
0
0
80
564
1.61
2.96
1.8
1.6
18.83
20.59
nmol/l
0.56
66
485
11
32
3.54
2.93
1.4
1.5
—
—
—
0
0
133
1057
1.53
2.89
3.9
2.9
153.79
112.49
ug/l
0.65
127
996
7
13
5.50
2.89
2.7
2.6
—
—
—
0
0
192
1660
1.61
2.82
5.3
4.0
14.77
14.72
pmol/l
0.10
182
1522
5
6
8.46
2.76
3.2
1.0
40.64
42.57
g/l
—
5
6
80
573
1.57
2.75
3.9
3.0
0.27
0.24
e6/l
0.09
62
415
7
14
5.11
2.74
1.1
1.8
—
—
—
0
0
126
1001
1.51
2.68
3.3
2.7
—
—
estimate
—
0
0
15
62
2.51
2.59
1.5
1.7
204.78
174.65
u/ml
—
9
37
8
21
3.90
2.48
2.1
1.8
—
—
—
0
0
8
21
3.90
2.48
2.1
1.8
—
—
—
0
0
8
21
3.90
2.48
2.1
1.8
—
—
—
0
0
178
1534
1.52
2.45
4.1
3.3
59.18
44.99
u/l
0.56
169
1471
12
47
2.63
2.30
3.8
3.1
7.39
5.43
umol/l
—
7
38
11
40
2.83
2.30
1.3
1.1
—
—
—
0
0
11
40
2.83
2.30
1.3
1.1
—
—
—
0
0
16
73
2.27
2.26
2.7
1.9
—
—
—
0
0
24
129
1.95
2.26
1.1
1.2
—
27.26
—
0
7
5
9
5.64
2.22
1.8
1.4
—
—
—
0
0
72
526
1.51
2.22
3.1
3.4
1115.73
1192.13
ng/l
0.06
67
439
53
362
1.58
2.20
1.3
1.3
12.24
10.50
u/ml
0.09
18
157
6
14
4.36
2.16
2.3
2.0
—
—
—
0
0
6
14
4.36
2.16
2.3
2.0
—
—
—
0
0
6
14
4.36
2.16
2.3
2.0
—
—
—
0
0
6
14
4.36
2.16
2.3
2.0
—
—
—
0
0
69
508
1.49
2.03
3.9
2.7
328.21
337.79
umol/l
0.37
61
457
30
180
1.75
2.03
3.7
3.1
—
—
—
0
0
5
11
4.61
1.95
1.2
1.0
1469.80
1487.73
miu/ml
—
5
11
5
11
4.61
1.95
2.6
2.2
—
—
—
0
0
5
11
4.61
1.95
2.6
2.2
—
—
—
0
0
5
11
4.61
1.95
2.6
2.2
—
—
—
0
0
18
93
2.01
1.90
1.4
1.7
—
—
—
0
0
19
101
1.95
1.86
3.9
2.3
1814.34
4706.12
u/l
—
10
37
6
17
3.59
1.85
1.8
1.7
3.23
5.01
mg/l
—
6
17
7
23
3.10
1.81
1.1
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
14
3.62
1.62
1.2
1.2
—
—
—
0
0
5
15
3.38
1.53
1.2
1.3
—
—
—
0
0
31
204
1.59
1.52
11.0
8.4
-0.00
0.84
mmol/l
0.62
24
171
13
65
2.05
1.51
1.2
1.2
0.21
3.12
u/ml
—
8
40
38
264
1.52
1.48
8.9
7.6
104.61
104.40
mmol/l
0.09
38
264
79
630
1.37
1.47
7.0
3.9
20.37
9.88
mg/mmol
0.50
52
395
7
28
2.54
1.46
3.3
1.8
—
—
—
0
0
9
39
2.35
1.44
2.7
1.7
—
—
—
0
0
32
216
1.55
1.42
2.4
2.0
—
—
—
0
0
21
127
1.71
1.41
19.9
11.4
24.93
24.77
mmol/l
0.07
21
127
10
47
2.17
1.35
1.5
1.5
—
—
—
0
0
26
169
1.60
1.35
1.5
1.4
—
—
—
0
0
43
313
1.45
1.34
1.6
1.5
—
—
—
0
0
18
106
1.75
1.33
1.5
1.4
—
—
—
0
0
5
18
2.81
1.29
3.2
1.9
11.00
10.09
mmol/l
—
5
18
40
291
1.44
1.25
2.1
1.6
1128.18
1169.70
nmol/l
0.11
35
229
6
25
2.43
1.25
3.5
1.8
—
—
—
0
0
129
1125
1.29
1.25
4.6
3.3
0.00
0.00
estimate
-0.00
29
240
131
1145
1.29
1.24
4.6
3.4
0.00
0.00
estimate
-0.00
29
233
5
19
2.66
1.22
1.2
1.0
—
—
—
0
0
14
79
1.82
1.19
1.4
1.4
—
—
—
0
0
6
26
2.34
1.19
1.2
1.1
—
—
—
0
0
50
384
1.37
1.17
1.6
1.7
448.57
35030381.24
pmol/l
0.50
44
334
26
176
1.53
1.16
2.3
1.9
—
—
—
0
0
64
513
1.33
1.14
1.9
1.7
—
—
—
0
0
7
30
2.37
1.13
1.6
1.6
—
—
—
0
0
7
31
2.29
1.11
1.3
1.6
—
—
—
0
0
7
31
2.29
1.11
1.3
1.6
—
—
—
0
0
7
31
2.29
1.11
1.3
1.6
—
—
—
0
0
5
21
2.41
1.09
13.0
17.3
534.80
938.48
nmol/l
—
5
21
102
875
1.27
1.09
1.9
1.9
1.38
1.39
mmol/l
0.03
85
754
46
353
1.37
1.08
2.3
2.2
—
—
—
0
0
49
383
1.34
1.03
2.4
2.3
—
—
—
0
0
11
61
1.84
1.00
1.1
1.1
—
—
—
0
0
42
322
1.36
1.00
3.3
3.0
6.46
2.71
e6/l
0.43
21
159
34
252
1.40
0.98
3.8
3.2
4.29
8.67
umol/l
2.12
28
220
0
30
0.00
0.98
0.0
1.8
—
—
—
0
0
87
741
1.26
0.97
4.5
3.5
53.10
114.67
ng/l
0.32
63
487
11
62
1.81
0.95
1.1
1.1
—
—
—
0
0
127
1134
1.24
0.92
4.7
3.3
0.00
0.00
estimate
-0.00
29
245
166
1527
1.24
0.91
3.9
3.3
—
—
—
0
0
44
346
1.33
0.90
3.2
2.8
0.80
1.00
e6/l
0.29
24
181
6
30
2.02
0.87
1.3
1.7
—
—
—
0
0
15
96
1.60
0.86
1.6
1.5
22.38
24.12
iu/l
—
10
83
6
31
1.96
0.85
1.3
1.6
—
—
—
0
0
6
31
1.96
0.85
1.3
1.6
—
—
—
0
0
209
1981
1.29
0.84
6.6
4.8
1.77
1.84
mu/l
0.45
203
1845
8
47
1.72
0.81
1.8
1.4
—
—
—
0
0
8
48
1.69
0.79
9.1
1.1
0.00
0.00
g/l
—
8
48
5
24
2.10
0.75
1.4
1.6
—
—
—
0
0
5
24
2.10
0.75
1.4
1.1
—
—
—
0
0
5
24
2.10
0.75
1.8
1.1
—
—
—
0
0
7
39
1.82
0.73
1.3
1.4
—
—
—
0
0
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
5
25
2.02
0.73
1.4
1.1
—
—
—
0
0
214
2045
1.27
0.73
22.4
12.6
87.64
86.66
ml/min/173m2
0.26
201
1865
11
68
1.65
0.73
1.5
1.4
—
—
—
0
0
5
26
1.94
0.71
1.4
1.6
—
—
—
0
0
18
127
1.45
0.70
1.1
1.3
—
—
—
0
0
59
502
1.23
0.66
3.9
3.2
1.00
1.02
kg/l
0.48
47
319
11
71
1.57
0.63
1.2
1.3
—
—
—
0
0
71
620
1.20
0.62
5.0
3.4
0.00
0.00
estimate
-0.00
28
228
21
158
1.36
0.59
1.8
2.5
72.88
70.48
ml/min/173m2
—
10
66
6
96
0.62
0.53
1.2
1.1
1.51
1.56
g/l
—
6
96
12
83
1.47
0.52
1.3
2.2
—
—
—
0
0
23
181
1.30
0.50
2.7
5.2
2.71
32.64
ug/l
0.70
16
151
10
68
1.49
0.47
3.8
2.4
23.12
24.59
mmol/l
—
10
68
65
577
1.17
0.47
1.6
1.3
0.81
1.27
u/ml
0.68
16
160
70
626
1.16
0.46
4.2
4.9
5.87
2.41
ug/l
0.37
56
567
54
477
1.17
0.42
2.0
1.8
2.04
1.23
mg/l
0.41
43
371
93
855
1.14
0.42
4.5
3.2
0.00
0.00
estimate
0.50
22
211
5
33
1.53
0.41
1.2
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
10.60
—
0
15
8
59
1.37
0.41
1.6
1.6
30.70
51.74
ug/l
—
8
59
0
16
0.00
0.41
0.0
1.0
—
580.56
—
0
9
0
16
0.00
0.41
0.0
1.0
—
36.25
—
0
8
5
35
1.44
0.39
6.0
2.9
10.86
8.05
pmol/l
—
5
35
9
66
1.38
0.39
1.3
1.6
—
—
—
0
0
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
14
109
1.30
0.34
5.8
2.6
0.59
0.61
%
0.10
14
109
28
240
1.19
0.32
5.4
4.7
30.32
31.39
%
0.28
22
163
7
98
0.71
0.31
1.7
1.1
0.80
0.93
g/l
—
7
98
5
41
1.22
0.22
1.6
1.3
—
—
—
0
0
5
42
1.19
0.21
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
10.55
—
0
11
0
12
0.00
0.21
0.0
1.3
—
15.17
—
0
12
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
5
43
1.17
0.21
1.0
1.1
—
2.24
—
0
10
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
205
2079
0.93
0.14
5.2
4.7
1.39
1.46
mmol/l
1.50
191
1954
208
2107
0.93
0.13
6.2
5.3
2.72
2.74
mmol/l
0.16
195
1988
67
641
1.06
0.13
4.1
2.9
0.00
0.00
estimate
-0.00
24
197
203
2002
1.07
0.13
5.7
4.6
5.96
5.83
mmol/l
0.53
189
1859
206
2086
0.94
0.12
5.4
4.7
4.57
4.66
mmol/l
0.60
193
1970
201
1985
1.06
0.11
4.5
4.0
1.34
1.28
mmol/l
0.47
188
1860
8
74
1.08
0.07
1.9
1.7
—
—
—
0
0
50
490
1.03
0.02
4.0
4.4
25.45
22.48
%
0.32
17
247
22
221
1.00
0.00
10.7
6.6
—
—
—
0
0
13
133
0.98
0.00
1.0
1.0
—
—
—
0
0
37
375
0.98
0.00
3.2
2.9
0.53
0.77
ug/l
2.00
25
235
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
7.77
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
26.93
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
60.40
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
200.88
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
75
0.93
-0.00
1.0
1.1
—
9.68
—
0
11
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
-0.00
1.9
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_ORBITINFLAMACU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ORBITINFLAMACU | 1.673 [1.29, 2.17] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.21 |
During the follow-up period (1.1.1998 — 31.12.2019), 110 out of 905 females with H7_ORBITINFLAMACU died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ORBITINFLAMACU | 1.943 [1.47, 2.57] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 135 out of 1125 males with H7_ORBITINFLAMACU died.
Mortality risk
Mortality risk for people of age
years, who have H7_ORBITINFLAMACU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.162% | 0.408% |
| 5 | 0.981% | 2.215% |
| 10 | 2.452% | 5.405% |
| 15 | 4.582% | 9.94% |
| 20 | 7.866% | 16.688% |
Relationships between endpoints
↥Index endpoint: H7_ORBITINFLAMACU – Acute inflammation of orbit
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data